Coyne Christine
SEC insider (Form 3/4/5 filer). CIK 0001861840. Chief Commercial Officer at Iterum Therapeutics plc (ITRM). 1 reported Form 4/5 transaction since Sep 2024; latest on Jul 1, 2025. Located in DUBLIN 1, L2.
Companies Coyne Christine has filed insider reports for
- Iterum Therapeutics plc (ITRM): Officer, Chief Commercial Officer
Coyne Christine
CIK: 0001861840
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ITRM
Iterum Therapeutics plc
Officer